[go: up one dir, main page]

AU1666583A - 1,2,5-thiadiazole derivatives - Google Patents

1,2,5-thiadiazole derivatives

Info

Publication number
AU1666583A
AU1666583A AU16665/83A AU1666583A AU1666583A AU 1666583 A AU1666583 A AU 1666583A AU 16665/83 A AU16665/83 A AU 16665/83A AU 1666583 A AU1666583 A AU 1666583A AU 1666583 A AU1666583 A AU 1666583A
Authority
AU
Australia
Prior art keywords
thiadiazole derivatives
thiadiazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16665/83A
Other languages
English (en)
Inventor
David Edmund Bays
Roger Hayes
John Wilson Macfarlane Mackinnon
Barry John Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU1666583A publication Critical patent/AU1666583A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AU16665/83A 1982-07-08 1983-07-08 1,2,5-thiadiazole derivatives Abandoned AU1666583A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8219746 1982-07-08
GB8219746 1982-07-08

Publications (1)

Publication Number Publication Date
AU1666583A true AU1666583A (en) 1984-01-12

Family

ID=10531541

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16665/83A Abandoned AU1666583A (en) 1982-07-08 1983-07-08 1,2,5-thiadiazole derivatives

Country Status (11)

Country Link
JP (1) JPS5927880A (de)
AU (1) AU1666583A (de)
BE (1) BE897247A (de)
DE (1) DE3324771A1 (de)
DK (1) DK317283A (de)
FR (1) FR2532937A1 (de)
GB (1) GB2124622A (de)
IT (1) IT8348653A0 (de)
NL (1) NL8302450A (de)
SE (1) SE8303913L (de)
ZA (1) ZA835009B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567191A (en) * 1983-06-07 1986-01-28 Merck & Co., Inc. Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors
DE3326545A1 (de) * 1983-07-22 1985-01-31 Ludwig Heumann & Co GmbH, 8500 Nürnberg Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
MXPA05003867A (es) 2002-10-09 2005-11-23 Schering Corp Tiadiazoldioxidos y tiadiazoloxidos como ligandos de receptor cxc-y cc-quimiocina.
ES2308299T3 (es) 2003-12-19 2008-12-01 Schering Corp Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas.
MXPA06007205A (es) 2003-12-22 2006-08-31 Schering Corp Dioxidos de isotiazol como ligandos del receptor cxc y cc-quimiocina.
CN101253180B (zh) 2005-06-29 2011-08-03 先灵公司 作为cxc-化学活素受体配体的5，6-二取代的*二唑吡嗪和噻二唑吡嗪
CA2613607A1 (en) 2005-06-29 2007-01-04 Schering Corporation Di-substituted oxadiazoles as cxc-chemokine receptor ligands
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0040696B1 (de) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazole als gastrische Inhibitoren
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors

Also Published As

Publication number Publication date
DE3324771A1 (de) 1984-01-12
GB8318525D0 (en) 1983-08-10
SE8303913D0 (sv) 1983-07-08
IT8348653A0 (it) 1983-07-08
ZA835009B (en) 1985-02-27
SE8303913L (sv) 1984-01-09
NL8302450A (nl) 1984-02-01
DK317283A (da) 1984-01-09
FR2532937A1 (fr) 1984-03-16
BE897247A (fr) 1984-01-09
JPS5927880A (ja) 1984-02-14
GB2124622A (en) 1984-02-22
DK317283D0 (da) 1983-07-08

Similar Documents

Publication Publication Date Title
AU551039B2 (en) Amino-1,2,5-thiadiazole derivatives
AU565087B2 (en) 1,4-dihydro-4-oxonaphthyridine derivatives
AU570667B2 (en) 2-phenyl-3-oxo-3,4-dihydro-benzothiazine(1,4) derivatives
AU7338081A (en) 1,2,4-triazolylpropenol derivatives
AU563950B2 (en) 2,2 -disubstituted-1,3-oxepine derivatives
AU1666583A (en) 1,2,5-thiadiazole derivatives
AU2956484A (en) Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives
AU1792983A (en) 2,3-dihydrobenzofurans
AU1575383A (en) 1,4-dihyropyridine derivatives
AU544881B2 (en) 3-aryl-5, 6-dihydro-1, 4, 2-oxathiazines
AU8413382A (en) 1,4-piperizine derivatives
AU568295B2 (en) 1,2,4-triazol-i-yl-propionitrile derivatives
AU4023085A (en) 1,2,4-triazacycloalkadiene derivatives
AU1741583A (en) 1,4-benzothiazine derivatives
AU557580B2 (en) 15-cycloaliphatic derivatives of 13,14-didehydro- carboprostacyclins
AU551883B2 (en) 2,5-bis-perfluoroalkyl-3,4-dicarbonylalkoxypyrroles
AU1176983A (en) 2,3-dihydro-1h-pyrrolizines
AU8879882A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU572869B2 (en) 1,6-naphthyridin derivatives
AU1974283A (en) 2,3-dihydro-2,2-dimethyl-benzofuran derivatives
AU636164B2 (en) 2,3-dihydro-1-hydroxy-3-oxo-2-(1-substituted-4-piperidinyl)- 1N-isoindole derivatives
AU3339584A (en) 1,2,4-triazolylmethyl - pyridyloxymethyl - carbinol derivatives
AU8879782A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU7744681A (en) 2,3-dihydro-4-pyrone derivatives
AU550530B2 (en) 1,1,2-triphenylbut-1-ene derivatives